Engineered nanoscale multicomponent particles are introduced and are called “quants.” Methods and apparatuses for producing such multicomponent nanoparticles are provided. A single quant can be manufactured to contain a variety of different internal component molecules. Likewise, a plurality of such quants may be manufactured wherein the plurality of quants are suspended in an aqueous solution. Typically, quants are produced in quantity and concentration adequate to support human scale therapeutics. In some embodiments, millions or billions of quants are suspended in a volume of aqueous solution for delivery to a patient. When manufactured to the same specification, the plurality of quants are uniform in size, uniform in chemical composition, and therefore uniform in functionality. Functional uniformity is an essential aspect of quants, manifested in design and production. By controlling the variables of manufacture, such as particle size and composition, and by redefining a drug dose as the measured number of quants delivered (as opposed to measuring a drug dose by the mass of its active ingredient), the performance of these nanoparticle-based drugs introduce significant efficiencies and much higher value products to the expanding therapeutics market.Cette invention concerne des nanoparticules multicomposants modifiées appelées "quants". Des procédés et des appareils de production desdites nanoparticules multicomposants sont décrits. Un seul quant peut être fabriqué pour contenir diverses molécules de composants internes différentes. De la même manière, une pluralité de quants peuvent être fabriqués, où la pluralité de quants est en suspension dans une solution aqueuse. Généralement, les quants sont produits en une quantité et à une concentration adéquates pour supporter des agents thérapeutiques à l'échelle humaine. Dans certains modes de réalisation, des millions ou des milliards de quants sont en suspension dans un volume de solution aqueuse à des fins d'adminis
